MedPath

MATRICELAB INNOVE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study

Not yet recruiting
Conditions
Infertility
Success Rate of Assisted Reproductive Therapy
Single Embryo Transfer
Pregnancy Outcomes
Immunological Tolerance
Immune System
First Posted Date
2024-07-16
Last Posted Date
2024-12-27
Lead Sponsor
Matricelab Innove
Target Recruit Count
340
Registration Number
NCT06503952
Locations
🇫🇷

Hopital des diaconnesse- Centre d'assistance medicale a la procreation, Paris, ile de France, France

🇫🇷

Hopital des Bluets- centre d'assistance medicale à la procreation, Paris, Ile de, France

News

Breakthrough Study: Endometrial Immune Profiling Boosts IVF Success Rates by 40%

A landmark randomized controlled trial by MatriceLab Innove demonstrates that personalized treatment based on endometrial immune profiling increases IVF live birth rates from 29.7% to 41.4%.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.